completed
ACTIVE BETWEEN: 2018-2021

China TB Case Finding Strategic Partnership Program

Johnson & Johnson collaborated with the China CDC to improve TB and RR-TB case detection across several regions in China covering 10 million people.
SGDS CONTRIBUTING TO:
SHOW SUB-TARGETS + HIDE SUB-TARGETS -
MEMBER COMPANIES:
Objectives

The initiative was aimed at improving TB case detection and patient finding across several regions of China.

From 2018-2021, Johnson & Johnson collaborated with the National Health Commission (NHC), China CDC and Cepheid to improve TB/MDR-TB patient detection for 10 million individuals in 22 counties of 3 western provinces by introducing quick diagnostic technology and performing medical trainings for local health care providers.

Geographic Reach
  • Western Pacific
See Where
Disease Area
  • Infectious and Parasitic Disease
See Disease Areas
Additional resources

FURTHER READING